**Core Concept**
The induction phase of antifungal therapy involves the immediate treatment of serious fungal infections with a potent antifungal agent to rapidly reduce fungal load and prevent progression of the disease. This phase is critical in severe fungal infections such as invasive aspergillosis, candidemia, or cryptococcal meningitis.

**Why the Correct Answer is Right**
The correct answer involves the use of echinocandins, which are a class of antifungal agents that inhibit the synthesis of beta-1,3-D-glucan, a key component of the fungal cell wall. Echinocandins, such as caspofungin, micafungin, and anidulafungin, are highly effective against Aspergillus species and other filamentous fungi, making them ideal for induction therapy in severe aspergillosis. They work by binding to the enzyme glucan synthase, which is essential for the synthesis of beta-1,3-D-glucan, ultimately leading to fungal cell lysis and death.

**Why Each Wrong Option is Incorrect**
* **Option A:** **Amphotericin B** is a polyene antifungal agent that is also used for induction therapy in serious fungal infections, but it has a narrower spectrum of activity compared to echinocandins and is associated with more toxicity.
* **Option B:** **Fluconazole** is a triazole antifungal agent that is commonly used for maintenance therapy in fungal infections, but it is not the preferred agent for induction therapy due to its slower onset of action and lower efficacy against Aspergillus species.
* **Option C:** **Posaconazole** is another triazole antifungal agent that is used for prophylaxis and maintenance therapy, but it is not typically used for induction therapy in serious fungal infections.

**Clinical Pearl / High-Yield Fact**
The choice of antifungal agent for induction therapy depends on the severity of the infection, the patient's underlying condition, and the suspected causative pathogen. In general, echinocandins are preferred for induction therapy in severe aspergillosis, while amphotericin B is often used for other types of serious fungal infections.

**Correct Answer:** C.